Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Stocks held by Nippon India Pharma Fund

#Stock NamePrevious Number of Shares ▲▼Previous Date ▲▼Current Number of Shares ▲▼Percentage Change ▲▼Last Changed ▲▼
1Mankind Pharma Ltd1,961,6332024-09-29900,794-54.08%2024-10-05
2Abbott India Ltd76,3902024-09-2976,3900.00%2024-10-05
3Torrent Pharmaceuticals Ltd2,309,2532024-09-30603,364-73.87%2024-10-05
4Thyrocare Technologies Ltd1,765,8382024-09-291,765,8380.00%2024-10-05
5Sun Pharmaceuticals Industries Ltd14,074,2372024-09-296,556,349-53.42%2024-10-05
6Sanofi India Ltd161,0002024-10-04236,00846.59%2024-10-05
7Pfizer Ltd224,3822024-09-29293,24930.69%2024-10-05
8Orchid Pharma Ltd1,534,9192024-10-041,000,000-34.85%2024-10-05
9Narayana Hrudayalaya Ltd1,801,1892024-10-041,849,5712.69%2024-10-05
10Jubilant Pharmova Ltd3,1702024-10-04550,33917,260.85%2024-10-05
11J B Chemicals & Pharmaceuticals Ltd1,588,9762024-10-041,486,868-6.43%2024-10-05
12Indoco Remedies Ltd1,362,7002024-10-041,834,92434.65%2024-10-05
13Healthcare Global Enterprises Ltd922024-10-04400,432435,152.17%2024-10-05
14Glaxosmithkline Pharmaceuticals Ltd839,1792024-09-29853,9071.76%2024-10-05
15Gland Pharma Ltd1,500,0002024-09-291,500,0000.00%2024-10-05
16Dr Reddys Laboratories Ltd550,0302024-09-29550,0300.00%2024-10-05
17Dr Lal Pathlabs Ltd425,0002024-09-29425,0000.00%2024-10-05
18Astrazeneca Pharma India Ltd11,5612024-09-2911,5610.00%2024-10-05
19Apollo Hospitals Enterprise Ltd1,426,3572024-09-29648,795-54.51%2024-10-05
20Alkem Laboratories Ltd452,4002024-10-04377,412-16.58%2024-10-05
21Ajanta Pharma Ltd510,5212024-10-04968,21489.65%2024-10-05

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.